All Stories

  1. Reference Standard for Validation of Age-Related Macular Degeneration Screening Algorithms
  2. Reduction in Pigment Epithelial Detachment Thickness with Faricimab vs Aflibercept 2 mg During Head-to-Head Dosing in TENAYA/LUCERNE
  3. ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR STAGES 3 AND 4 PROLIFERATIVE SICKLE CELL RETINOPATHY RESULTS IN IMPROVED ANATOMICAL AND VISUAL OUTCOMES
  4. Blind Spots: Patient Knowledge and Practices around Ocular Complications in Sickle Cell Disease
  5. LONGITUDINAL OUTCOMES STUDY OF SUTURELESS SCLERAL-FIXATED INTRAOCULAR LENSES
  6. Deep learning segmentation of periarterial and perivenous capillary-free zones in optical coherence tomography angiography
  7. Anatomic Control with Faricimab versus Aflibercept in the YOSEMITE/RHINE Trials in Diabetic Macular Edema
  8. Response of Diabetic Macular Edema to Anti-VEGF Medications Correlates with Improvement in Macular Vessel Architecture Measured with OCT Angiography
  9. Ocular and Systemic Risk Factors for Disease Worsening Among Patients with NPDR
  10. The 0.19-mg Fluocinolone Acetonide Intravitreal Implant for Diabetic Macular Edema
  11. METformin FOR the MINimization of Geographic Atrophy Progression (METforMIN) – A Randomized Trial
  12. Federated Learning in Diagnosing Age-Related Macular Degeneration
  13. Optimizing the OCTA layer fusion option for deep learning classification of diabetic retinopathy
  14. Federated Learning for Diagnosis of Age-related Macular Degeneration
  15. COMPARATIVE ANALYSIS OF OCT AND OCT ANGIOGRAPHY CHARACTERISTICS IN EARLY DIABETIC RETINOPATHY
  16. Contrastive learning-based pretraining improves representation and transferability of diabetic retinopathy classification models
  17. Normalized Blood Flow Index in Optical Coherence Tomography Angiography Provides a Sensitive Biomarker of Early Diabetic Retinopathy
  18. Multi-fusion strategies for deep learning artery and vein segmentation in OCT angiography
  19. Comparison of AI and dilated eye exams for the detection of diabetic retinopathy
  20. Simulation of long-term impact of intravitreal anti-VEGF therapy on patients with severe non-proliferative diabetic retinopathy
  21. Visual Field Abnormalities in Early-Stage Diabetic Retinopathy Assessed by Chromatic Perimetry
  22. Rhegmatogenous retinal detachment surgery: A review
  23. Automated Region of Interest Selection Improves Deep Learning-Based Segmentation of Hyper-Reflective Foci in Optical Coherence Tomography Images
  24. AVA-Net: an open-source deep learning network for arterial-venous area segmentation in OCT angiography
  25. Contrastive learning-based pretraining improves representation and transferability of diabetic retinopathy classification models
  26. MF-AV-Net: an open-source deep learning network with multimodal fusion options for artery-vein segmentation in OCT angiography
  27. QUANTITATIVE OPTICAL COHERENCE TOMOGRAPHY REVEALS ROD PHOTORECEPTOR DEGENERATION in EARLY DIABETIC RETINOPATHY
  28. From Data to Deployment
  29. Comparative feature analysis in OCT and OCT angiography of diabetic retinopathy
  30. Quantitative features for objective assessment of OCT angiography
  31. Pivotal Evaluation of an Artificial Intelligence System for Autonomous Detection of Referrable and Vision-Threatening Diabetic Retinopathy
  32. Imaging and artificial intelligence for progression of age-related macular degeneration
  33. Bilateral Macular Schisis in a Woman
  34. Probabilistic Forecasting of Anti-VEGF Treatment Frequency in Neovascular Age-Related Macular Degeneration
  35. Closure of Full-Thickness Macular Holes Associated with Macular Edema with Medical Therapy
  36. Prevention of Severe Nonproliferative Diabetic Retinopathy Progression With More at Stake Than Visual Acuity
  37. Deep learning artery-vein classification in OCT angiography
  38. Longitudinal Assessment of Retinal Thinning in Adults With and Without Sickle Cell Retinopathy Using Spectral-Domain Optical Coherence Tomography
  39. Sickle Cell Retinopathy
  40. AV-Net: deep learning for fully automated artery-vein classification in optical coherence tomography angiography
  41. Reply
  42. Transfer Learning for Automated OCTA Detection of Diabetic Retinopathy
  43. VASCULAR COMPLEXITY ANALYSIS IN OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF DIABETIC RETINOPATHY
  44. Quantitative analysis of vascular complexity in OCTA of diabetic retinopathy
  45. Deep learning for objective OCTA detection of diabetic retinopathy
  46. Retinal Vein Occlusions Preferred Practice Pattern®
  47. Idiopathic Macular Hole Preferred Practice Pattern®
  48. Retinal and Ophthalmic Artery Occlusions Preferred Practice Pattern®
  49. Idiopathic Epiretinal Membrane and Vitreomacular Traction Preferred Practice Pattern®
  50. ADVERSE EVENTS OF THE ARGUS II RETINAL PROSTHESIS
  51. QUANTITATIVE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY FEATURES FOR OBJECTIVE CLASSIFICATION AND STAGING OF DIABETIC RETINOPATHY
  52. Diabetic Retinopathy Preferred Practice Pattern®
  53. Age-Related Macular Degeneration Preferred Practice Pattern®
  54. Posterior Vitreous Detachment, Retinal Breaks, and Lattice Degeneration Preferred Practice Pattern®
  55. “Iodine Allergy” and the Use of Povidone Iodine for Endophthalmitis Prophylaxis
  56. AMPLITUDE LOSS OF THE HIGH-FREQUENCY FLICKER ELECTRORETINOGRAM IN EARLY DIABETIC RETINOPATHY
  57. Relating retinal blood flow and vessel morphology in sickle cell retinopathy
  58. Contrast sensitivity is associated with outer‐retina thickness in early‐stage diabetic retinopathy
  59. Hypotony and the Argus II retinal prosthesis: causes, prevention and management
  60. Simulating vascular leakage on optical coherence tomography angiography using an overlay technique with corresponding thickness maps
  61. Supervised Machine Learning Based Multi-Task Artificial Intelligence Classification of Retinopathies
  62. Longitudinal Study of Peripapillary Thinning in Sickle Cell Hemoglobinopathies
  63. Bilateral Blurry Vision in a Human Leukocyte Antigen B27–Positive Man
  64. Electrophysiological and pupillometric measures of inner retina function in nonproliferative diabetic retinopathy
  65. Fully automated geometric feature analysis in optical coherence tomography angiography for objective classification of diabetic retinopathy
  66. Differential Artery–Vein Analysis Improves the Performance of OCTA Staging of Sickle Cell Retinopathy
  67. OCT feature analysis guided artery-vein differentiation in OCTA
  68. Quantitative artery-vein analysis in optical coherence tomography angiography of diabetic retinopathy
  69. Management of severe retinal detachment
  70. Natural History of Drusenoid Pigment Epithelial Detachment Associated with Age-Related Macular Degeneration
  71. Diagnostic accuracy and reliability of retinal pathology using the Forus 3nethra fundus camera compared to ultra wide-field imaging
  72. Progression of Geographic Atrophy in Age-related Macular Degeneration
  73. Macular Vitelliform-Like Lesion in an Eye With Chronic Retinal Detachment
  74. Color Fundus Image Guided Artery-Vein Differentiation in Optical Coherence Tomography Angiography
  75. Association between Visual Acuity and Retinal Layer Metrics in Diabetics with and without Macular Edema
  76. COMPARISON OF VISUAL AND ANATOMICAL OUTCOMES OF EYES UNDERGOING TYPE I BOSTON KERATOPROSTHESIS WITH COMBINATION PARS PLANA VITRECTOMY WITH EYES WITHOUT COMBINATION VITRECTOMY
  77. Retinal Anatomy and Electrode Array Position in Retinitis Pigmentosa Patients After Argus II Implantation: An International Study
  78. Cyst Masquerading as Inadvertent Bleb After a Scleral-Fixated Intraocular Lens in Marfan Syndrome: A Case Report
  79. Analysis of Retinal Thinning Using Spectral-domain Optical Coherence Tomography Imaging of Sickle Cell Retinopathy Eyes Compared to Age- and Race-Matched Control Eyes
  80. Plasma Vascular Endothelial Growth Factor Concentrations after Intravitreous Anti–Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema
  81. Combining ODR and Blood Vessel Tracking for Artery–Vein Classification and Analysis in Color Fundus Images
  82. Comparison of Monthly vs Treat-and-Extend Regimens for Individuals With Macular Edema Who Respond Well to Anti–Vascular Endothelial Growth Factor Medications
  83. Automated classification and quantitative analysis of arterial and venous vessels in fundus images
  84. Global causes of blindness and distance vision impairment 1990–2020: a systematic review and meta-analysis
  85. Retinal Oximetry and Vessel Diameter Measurements With a Commercially Available Scanning Laser Ophthalmoscope in Diabetic Retinopathy
  86. Cholesterol Crystals Secondary to Coats-Like Response With Retinitis Pigmentosa
  87. Macula Society Collaborative Retrospective Study of Ocriplasmin for Symptomatic Vitreomacular Adhesion
  88. Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis
  89. YAG Laser Vitreolysis—Is It as Clear as It Seems?
  90. Computer-aided classification of sickle cell retinopathy using quantitative features in optical coherence tomography angiography
  91. Acute Vision Loss and Bilateral Macular Lesions
  92. Method for quantitative assessment of retinal vessel tortuosity in optical coherence tomography angiography applied to sickle cell retinopathy
  93. Profound Macular Ischemia on Optical Coherence Tomography Angiography in Severe Diabetic Retinopathy
  94. Pupillary responses in non-proliferative diabetic retinopathy
  95. Quantitative characteristics of sickle cell retinopathy in optical coherence tomography angiography
  96. Headaches and Foggy Vision in a 21-Year-Old Woman
  97. The Effects of Diabetic Retinopathy Stage and Light Flicker on Inner Retinal Oxygen Extraction Fraction
  98. Alterations in Retinal Layer Thickness and Reflectance at Different Stages of Diabetic Retinopathy by En Face Optical Coherence Tomography
  99. Initiation of intravitreal aflibercept injection treatment in patients with diabetic macular edema: a review of VIVID-DME and VISTA-DME data
  100. Worldwide Argus II implantation: recommendations to optimize patient outcomes
  101. Dissociations of the Fluocinolone Acetonide Implant: The Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study
  102. Chronic Visual Disturbance in a Young Healthy Man
  103. Painful Red Eye in a Woman in Her 70s
  104. Cross-Sectional analysis of neurocognitive function, retinopathy, and retinal thinning by Spectral-Domain optical coherence tomography in sickle cell patients
  105. Enface Thickness Mapping and Reflectance Imaging of Retinal Layers in Diabetic Retinopathy
  106. Factors Predicting Visual Acuity Outcome in Intermediate, Posterior, and Panuveitis: The Multicenter Uveitis Steroid Treatment (MUST) Trial
  107. Outcome of Treatment of Uveitic Macular Edema
  108. Blurred Vision in a Woman Who Had Sphenoid Wing Meningioma
  109. Surgical outcomes of 25-gauge pars plana vitrectomy for diabetic tractional retinal detachment
  110. New Pigmented Lesion Over a Site of Tumor Treatment
  111. Inner and Outer Retinal Thickness Mapping of Nonproliferative Diabetic Retinopathy by Spectral-Domain Optical Coherence Tomography
  112. Subconjunctival Hemorrhages and Retinal Vascular Abnormalities
  113. Conjunctival microvascular haemodynamics in sickle cell retinopathy
  114. One year results of a phase 1 study of the safety and tolerability of combination therapy using sustained release intravitreal triamcinolone acetonide and ranibizumab for subfoveal neovascular AMD
  115. Sudden-Onset Paracentral Vision Loss
  116. Wavefront Error Correction with Adaptive Optics in Diabetic Retinopathy
  117. Optical Coherence Tomography Retinal Thickness and Volume Measurements in X-Linked Retinoschisis
  118. Collaborative Retrospective Macula Society Study of Photodynamic Therapy for Chronic Central Serous Chorioretinopathy
  119. Cotton-Wool Spots and Retinal Hemorrhages
  120. Neural Constraints on Visual Acuity in Proliferative Diabetic Retinopathy
  121. A Method for En Face OCT Imaging of Subretinal Fluid in Age-Related Macular Degeneration
  122. INTRAVITREAL ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR FOR CHOROIDAL NEOVASCULARIZATION IN OCULAR HISTOPLASMOSIS
  123. Smudge in My Vision
  124. Human bulbar conjunctival hemodynamics in hemoglobin SS and SC disease
  125. Rapid response of retinal pigment epithelial detachments to intravitreal aflibercept in neovascular age-related macular degeneration refractory to bevacizumab and ranibizumab
  126. Peripapillary Retinal Nerve Fiber Layer Thickness in Sickle-Cell Hemoglobinopathies Using Spectral-Domain Optical Coherence Tomography
  127. MULTIFOCAL RETINAL ASTROCYTIC HAMARTOMAS
  128. Age-Related Macular Degeneration
  129. Ophthalmic manifestations of sickle cell disease
  130. EN FACE SPECTRAL-DOMAIN OPTICAL COHERENCE TOMOGRAPHY OUTER RETINAL ANALYSIS AND RELATION TO VISUAL ACUITY
  131. Object Frequency Characteristics of Visual Acuity
  132. Reply
  133. Feasibility of a Method for En Face Imaging of Photoreceptor Cell Integrity
  134. Structural and Functional Correlation in Sickle Cell Retinopathy Using Spectral-Domain Optical Coherence Tomography and Scanning Laser Ophthalmoscope Microperimetry
  135. Sustained-Release Intravitreal Liquid Drug Delivery Using Triamcinolone Acetonide for Cystoid Macular Edema in Retinal Vein Occlusion
  136. Central Macular Splaying and Outer Retinal Thinning in Asymptomatic Sickle Cell Patients by Spectral-Domain Optical Coherence Tomography
  137. Two-Year Outcomes of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study
  138. A COMPARISON OF HYPOXIA-INDUCIBLE FACTOR-α IN SURGICALLY EXCISED NEOVASCULAR MEMBRANES OF PATIENTS WITH DIABETES COMPARED WITH IDIOPATHIC EPIRETINAL MEMBRANES IN NONDIABETIC PATIENTS
  139. Chronic Coccidioidomycosis Endophthalmitis without Concomitant Systemic Involvement: A Clinicopathological Case Report
  140. REGRESSION OF CHOROIDAL NEOVASCULARIZATION AFTER VITRECTOMY FOR POSTINJECTION ENDOPHTHALMITIS
  141. Primary End Point (Six Months) Results of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study
  142. Prophylactic Treatment of Age-Related Macular Degeneration Report Number 2: 810-Nanometer Laser to Eyes With Drusen: Bilaterally Eligible Patients
  143. Reply
  144. Update on Laser Treatment of Diabetic Macular Edema
  145. Pharmacotherapy of age-related macular degeneration
  146. A Pilot Study of Fourier-Domain Optical Coherence Tomography of Retinal Dystrophy Patients
  147. Optical coherence tomography findings in paraneoplastic pseudovitelliform lesions in melanoma-associated retinopathy
  148. Primary transpupillary thermotherapy for small choroidal melanomas
  149. Presumed ocular tuberculosis presenting as a branch retinal vein occlusion in the absence of retinal vasculitis or uveitis
  150. Early onset vitreous amyloidosis in familial amyloidotic polyneuropathy with a transthyretin Glu54Gly mutation is associated with elevated vitreous VEGF
  151. Xanthogranuloma of the Iris Simulating Melanoma in an Adult
  152. New treatments for neovascular acute macular degeneration
  153. Pharmacotherapy for neovascular age-related macular degeneration: clinical trials and the art of medicine
  154. MACULAR DEGENERATION: THE LATEST IN CURRENT MEDICAL MANAGEMENT
  155. GROUP B STREPTOCOCCAL ENDOGENOUS ENDOPHTHALMITIS IN A NEONATE
  156. Prophylactic Treatment of Age-Related Macular Degeneration Report Number 1: 810-Nanometer Laser to Eyes with Drusen. Unilaterally Eligible Patients
  157. Photodynamic Therapy for Choroidal Neovascularisation Secondary to Inflammatory Chorioretinal Disease
  158. ONE-YEAR RESULTS OF A PILOT STUDY USING ORAL 13-CIS RETINOIC ACID AS A TREATMENT FOR SUBFOVEAL PREDOMINANTLY OCCULT CHOROIDAL NEOVASCULARIZATION IN PATIENTS WITH AGE-RELATED MACULAR DEGENERATION
  159. Hastening Choroidal Neovascularization: The Irony of Prophylactic Laser in Unilateral Eyes With High-Risk Drusen
  160. Sequential induction of angiogenic growth factors by TNF-α in choroidal endothelial cells
  161. Neuropilin-1 Expression by Endothelial Cells and Retinal Pigment Epithelial Cells in Choroidal Neovascular Membranes
  162. NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: ROUNDTABLE
  163. SCOTOMAS OF AGE-RELATED MACULAR DEGENERATION DETECTED AND CHARACTERIZED BY MEANS OF A NOVEL THREE-DIMENSIONAL COMPUTER-AUTOMATED VISUAL FIELD TEST
  164. Atypical Presentation of Multiple Evanescent White Dot Syndrome Involving Granular Lesions of Varying Size
  165. Outcomes of 140 Consecutive Cases of 25-Gauge Transconjunctival Surgery for Posterior Segment Disease
  166. Bartonella henselae infection presenting as a unilateral panuveitis simulating Vogt-Koyanagi-Harada syndrome
  167. Accumulation of NH2-Terminal Fragment of Connective Tissue Growth Factor in the Vitreous of Patients With Proliferative Diabetic Retinopathy
  168. Posterior uveal effusion syndrome after trabeculectomy in an eye with ocular venous congestion
  169. Diagnostic and Therapeutic Challenges
  170. Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia
  171. Episcleral plaque 125I radiotherapy with episcleral LCF hyperthermia: A prospective randomized trial
  172. Indocyanine green angiography in chorioretinal diseases: indications and interpretation
  173. Diabetic macular edema: review and update
  174. Macular disease
  175. Photodynamic therapy for choroidal neovascular disease: photosensitizers and clinical trials
  176. Update on pseudophakic cystoid macular edema treatment options
  177. Uveal metastasis 43 years after resection of bronchogenic carcinoid
  178. COMPARISON OF NONMYDRIATIC DIGITIZED VIDEO FUNDUS IMAGES WITH STANDARD 35-MM SLIDES TO SCREEN FOR AND IDENTIFY SPECIFIC LESIONS OF AGE-RELATED MACULAR DEGENERATION
  179. Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy
  180. A Randomized, Placebo-Controlled, Clinical Trial of High-Dose Supplementation With Vitamins C and E, Beta Carotene, and Zinc for Age-Related Macular Degeneration and Vision Loss
  181. A Randomized, Placebo-Controlled, Clinical Trial of High-Dose Supplementation With Vitamins C and E and Beta Carotene for Age-Related Cataract and Vision Loss
  182. Vitrectomy and membrane dissection surger: Author reply
  183. Exudative retinal detachment in relapsing polychondritis
  184. PARS PLANA VITRECTOMY FOR EPIRETINAL MEMBRANE SECONDARY TO CAT SCRATCH NEURORETINITIS
  185. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization—verteporfin in photodynamic th...
  186. Radioactive plaque therapy for metastatic choroidal carcinoma
  187. Submacular surgery trials randomized pilot trial of laser photocoagulation versus surgery for recurrent choroidal neovascularization secondary to age-related macular degeneration: i. ophthalmic outcomes submacular surgery trials pilot study report numb...
  188. Vitreoretinal surgery through multifocal intraocular lenses compared with monofocal intraocular lenses in fluid-filled and air-filled rabbit eyes
  189. A comparison of digital nonmydriatic fundus imaging with standard 35-millimeter slides for diabetic retinopathy
  190. Retina Vitreous-Macula
  191. Iatrogenic Choroidal Neovascularization
  192. Multiple evanescent white dot syndrome in older patients
  193. PARANEOPLASTIC RETINAL SYNDROMES
  194. Visual and anatomic outcomes associated with posterior segment complications after ganciclovir implant procedures in patients with AIDS and cytomegalovirus retinitis
  195. Macular Hole Surgery Using Thrombin-Activated Fibrinogen and Selective Removal of the Internal Limiting Membrane
  196. MACULAR HOLE SURGERY USING THROMBIN-ACTIVATED FIBRINOGEN AND SELECTIVE REMOVAL OF THE INTERNAL LIMITING MEMBRANE
  197. Histopathologic characteristics of uveal melanomas in eyes enucleated from the collaborative ocular melanoma study COMS report no. 6
  198. The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma I: characteristics of patients enrolled and not enrolled COMS report no. 9
  199. The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma II: initial mortality findings COMS report no. 10
  200. SYMPTOMATIC AGE-RELATED MACULAR DEGENERATION IN ASIAN PATIENTS
  201. Hydrogel Exoplant Fragmentation 10 Years After Scleral Buckling Surgery
  202. Indocyanine Green Angiography-guided Photocoagulation of Choroidal Neovascularization Associated With Retinal Pigment Epithelial Detachment
  203. Ultrapower surgical drill system evaluation
  204. Microbiologic Factors and Visual Outcome in the Endophthalmitis Vitrectomy Study
  205. Retained Lens Material Masquerading as a Growing, Pigmented Iris Tumor
  206. Ciliary Body Endophotocoagulation during Pars Plana Vitrectomy in Eyes with Vitreoretinal Disorders and Concomitant Uncontrolled Glaucoma
  207. Recent developments in indocyanine green angiography
  208. Postoperative Hypopyon After Intravitreal Bovine Thrombin for Macular Hole Surgery
  209. Anaphylactic Shock Following Indocyanine Green Angiography
  210. CLINICOPATHOLOGIC FEATURES OF INDOCYANINE GREEN ANGIOGRAPHY-IMAGED, SURGICALLY EXCISED CHOROIDAL NEOVASCULAR MEMBRANES
  211. RETINOBLASTOMA RECURRENCE AFTER IODINE 125 PLAQUE APPLICATION
  212. Submacular Hemorrhage Removal
  213. Selective Use of Indocyanine Green Angiography for Occult Choroidal Neovascularization
  214. Correspondence
  215. Indocyanine Green Angiography
  216. Subretinal Hemorrhage
  217. The Role of Gravity in Gentamicin-Induced Toxic Effects in a Rabbit Model
  218. Candidal Retinitis in a Gynecologic Patient
  219. Pilot Trial of Transscleral Diode Laser Retinopexy in Retinal Detachment Surgery-Reply
  220. Improved Visual Results after Surgical Repair of Cytomegalovirus-related Retinal Detachments
  221. ADENOMA OF THE NONPIGMENTED CILIARY EPITHELIUM
  222. Aminoglycoside Toxicity in the Treatment of Endophthalmitis
  223. Foveomacular Dystrophy
  224. A New Syndrome of Myelinated Nerve Fibers, Vitreoretinopathy, and Skeletal Malformations
  225. Laser Treatment of Choroidal Neovascularization in Patients With Angioid Streaks
  226. Pilot Trial of Transscleral Diode Laser Retinopexy in Retinal Detachment Surgery
  227. Intraocular Tissue Plasminogen Activator Concentrations after Subconjunctival Delivery
  228. VISUAL ABNORMALITIES ASSOCIATED WITH HIGH-ENERGY MICROWAVE EXPOSURE
  229. Late-onset Sterile Endophthalmitis After Molteno Tube Implantation
  230. Successful Treatment of Gram-negative Endophthalmitis With Intravitreous Ceftazidime
  231. ATYPICAL PARAFOVEAL TELANGIECTASIS WITH SUBSEQUENT ANTERIOR AND POSTERIOR SEGMENT NEOVASCULARIZATION
  232. Macular Hole Formation Following Laser Photocoagulation of Choroidal Neovascular Membranes in a Patient With Presumed Ocular Histoplasmosis
  233. What to tell the patient with optic neuritis about multiple sclerosis
  234. Intraocular Penetration of Topical Tissue Plasminogen Activator
  235. Anterior Granulomatous Uveitis in Patients with Multiple Sclerosis
  236. Brown-McLean Syndrome
  237. Penetrating Ocular Injury From Contaminated Eating Utensils
  238. A Retinal Pigment Epithelium Tear in a Patient With Angioid Streaks
  239. Assessment of Intraocular Pressure in Vitrectomized Gas-Containing Eyes
  240. Retinal Pigment Epithelium Tear in a Diabetic Patient With Exudative Retinal Detachment Following Panretinal Photocoagulation and Filtration Surgery
  241. Idiopathic Sclerochoroidal Calcification
  242. Comparison of the Challenger Digital Applanation Tonometer and the Goldmann Applanation Tonometer
  243. Ultraviolet light absorbing pseudophakos